Schonfeld Strategic Advisors LLC 13D/13G Filings for Terns Pharmaceuticals, Inc. (TERN)

Schonfeld Strategic Advisors LLC 13D and 13G filings for Terns Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-14
4:15 pm
Purchase
2024-12-31 13G Terns Pharmaceuticals, Inc.
TERN
Schonfeld Strategic Advisors LLC 5,234,508
6.160%
5,234,508increase
(New Position)
Filing